Filter
1310
Text search:
pharmaceutical
policies
Featured
119
359
Language
Document type
631
299
187
82
60
16
12
11
6
3
3
Countries / Regions
62
61
54
41
36
36
33
31
27
23
22
21
20
19
19
19
17
17
16
16
14
14
13
13
12
12
11
10
10
9
9
7
7
7
7
5
5
5
5
4
4
4
4
4
4
4
3
3
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
579
69
63
59
31
19
12
Toolboxes
156
103
102
72
69
44
35
32
31
26
23
22
21
19
19
14
11
10
7
5
4
4
3
3
1
Prices people pay for medicines.
Guidelines for Handling Temperature Sensitive Vaccines and Pharmaceuticals
Towards ending tuberculosis and multidrug-resistant tuberculosis.
(Health Systems in Transition, Vol. 4, No. 3, 2014)
In 2017, 3.6 million of the estimated 10 million people with TB worldwide were “missed” by national TB programmes (NTPs). Two thirds of them are thought to access TB treatment of questionable quality from public and private providers who are not engaged by the NTP. The quality of care provided i
...
Progress towards targets of the Global action plan on dementia
В этом дискуссионном документе излагаются факты, касающиеся передозировки опиоидов, мер, которые могут быть приняты в целях предупреждения и лечения (коррекции) п
...
UNAIDS 2017 / Reference
Generating evidence for policy and action on HIV and social protection
Technical Note on Antimicrobial Resistance
This document reflects UNICEF’s response to the growing global threat of AMR to child survival, growth and development. It identifies UNICEF’s AMR-specific and AMR-sensitive actions in reducing infections, promoting access to and optimal use of antimic
...
This is the first NAP on the Prevention and Containment of AMR in Kenya. It has been developed based on the National Policy on Prevention and Containment of AMR and the recommendations of the situation analysis on AMR conducted in 2011 and updated in 2016. This strategy provides a regulatory and imp
...
